Thiamphenicol in the treatment of extragenital gonorrhea.

One hundred ninety-two cases of gonorrhea, of which 23 were extragenital only or both genital and extragenital, were treated with a single oral dose of thiamphenicol (2.5 g in patients weighing less than or equal to 80 kg; 3 g in patients weighing greater than 80 kg). Of the 178 patients whose follow-up was possible, 176 patients (98.

[Clinical and microbiological aspects of peritonitis in patients treated with continuous ambulatory peritoneal dialysis].

Over a 3-year period 22 episodes of peritonitis were observed among 20 patients treated for end-stage renal failure by CAPD. This represents an overall incidence of 1 episode every 9.5 patient-months (1/14.

[Pharyngeal and anorectal gonorrhea. Incidence in Lausanne in 1981].

After a brief review of the literature on pharyngeal and anorectal gonorrhea, the authors report the incidence of this disease among 498 patients consulting for known or suspected venereal disease from January 1 to December 31 1981. 192 cases of gonorrhoea, of which 23 had extragenital localization, were treated with thiamphenicol (Urfamycine) in a single dose (2.5 g orally or 3 g in patients weighing over 80 kg).

[Sensitivity of Candida spp. to 5-fluorocytosine, amphotericin B and imidazoles. Antifongiogram of 120 strains isolated at the Vaudois University Hospital Center during the autumn-winter seasons of 1978 and 1980].

120 strains of Candida spp were tested against the antifungal agents 5-fluorocytosine, amphotericine B and the imidazoles econazole, miconazole and clotrimazole. The proportion of resistance varied with the species and substances: Candida albicans (100 strains): 4% resistance against 5-fluorocytosine, 1% against amphotericine B, no resistance to imidazoles; Candida tropicalis and C. pseudotropicalis (15 strains): 26.

[Urinary concentration and antibacterial effect of short and long acting tetracycyline].

Forty-one hospitalized patients, of whom the majority had asymptomatic bacteriuria, were randomly divided into 4 treatment groups. They were given either tetracycline HCl 1 g, or tetracycline HCl + terpenes 100 mg, or minocycline 200 mg, or cotrimoxazole (sulfamethoxazole 1.6 g + trimethoprim 320 mg), daily for one week.